Hubei Biocause Heilen Pharmaceutical Co., Ltd.
Status: Publicly traded
Direct answer
Hubei Biocause Heilen Pharmaceutical Co., Ltd. is publicly traded on SHZ under the ticker 301211.SZ.
Hubei Biocause Heilen Pharmaceutical Co., Ltd. is a Chinese enterprise with diverse operations spanning the pharmaceutical, chemical, and new energy fuel sectors. Within its pharmaceutical segment, the company manufactures active pharmaceutical ingredients (APIs), various intermediates, and finished drug formulations. Furthermore, its chemical offerings include industrial products such as dimethyl ether gas and...
Can you invest in Hubei Biocause Heilen Pharmaceutical Co., Ltd.?
Yes. Hubei Biocause Heilen Pharmaceutical Co., Ltd. trades publicly on SHZ as 301211.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Hubei Biocause Heilen Pharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.